Abstract
The cytokine IFNγ is a principal effector of macrophage activation and immune resistance to mycobacterial infection; however, pathogenic mycobacteria are capable of surviving in IFNγ-activated macrophages by largely unknown mechanisms. In this study, we find that pathogenic mycobacteria, including M. bovis BCG and M. tuberculosis can sense IFNγ to promote their proliferative activity and virulence phenotype. Moreover, interaction with the host intracellular environment increases the susceptibility of mycobacteria to IFNγ through upregulating expression of mmpL10, a mycobacterial IFNγ receptor, thereby facilitating IFNγ-dependent survival and growth of mycobacteria in macrophages. Transmission electron microscopy analysis reveals that IFNγ triggers the secretion of extracellular vesicles, an essential virulence strategy of intracellular mycobacteria, while proteomics identifies numerous pivotal IFNγ-induced effectors required for mycobacterial infection in macrophages. Our study suggests that sensing host IFNγ is a crucial virulence mechanism used by pathogenic mycobacteria to survive and proliferate inside macrophages.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Mycobacterium tuberculosis is arguably the most successful pathogen on earth and continues to cause an estimated 1.5 million casualties annually. A critical virulence strategy relies on the survival of mycobacteria within host macrophages [11]. Macrophage cells are essential immune effectors at the front line of host defense against mycobacterial infection. They express receptors that allow them to uptake and degrade pathogens using an array of different effector mechanisms, followed by activating the immune system through a so-called cross-presentation [9]. However, pathogenic mycobacteria can circumvent and dampen many host anti-mycobacterial effects, primarily by as-yet-unknown mechanisms, thereby establishing a niche to survive and proliferate inside the host cells [1].
Cytokines are essential for the immune response of macrophages to mycobacterial infection. Each cytokine binds to a specific surface receptor to activate downstream signaling cascade(s) that may enhance or attenuate anti-mycobacterial effects in macrophages [3, 13]. However, numerous pathogenic bacteria such as Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa and Neisseria meningitidis have been found to directly sense host cytokines to facilitate their invasion and survival [28, 30, 39, 65], suggesting that sensing of host cytokines may be an evolutionarily conserved virulence mechanism in pathogenic bacteria that recognizes host immune activation.
Intriguingly, Ahmed et al. recently uncovered that M. tuberculosis can interact with IFNγ via its membrane protein MmpL10 to augment its fitness; however, interaction with IFNγ also increases the sensitivity of M. tuberculosis to isoniazid, an antibiotic indicated in the first-line treatment of TB [2]. Interferon-γ is a key immune effector activating the anti-microbial effect in antigen-presenting cells and protective-immune responses against mycobacterial infection. An important macrophage activation occurs via IFNγ, thereby converting naïve macrophages, in which mycobacteria can survive, into cells that readily destroy the incoming mycobacteria [20, 29], suggesting that recognition of IFNγ may be an unknown virulence mechanism of intracellular mycobacteria to recognize macrophage activation. Therefore, this study is aimed at investigating the molecular changes in pathogenic mycobacteria triggered by IFNγ and how they impact the mycobacteria-macrophage interactions.
Results
Direct interaction of IFNγ with M. Bovis BCG
Since the sequence of the mmpl10 gene in M. bovis BCG is identical to that in M. tuberculosis H37Rv, we tested whether IFNγ can also bind to M. bovis BCG. First, M. bovis BCG was fixed, incubated with different concentrations of IFNγ (active or heat-inactivated form), BSA or other cytokines including interleukin-12 (IL12), interleukin-1β (IL1β), and interleukin-18 (IL18), and analyzed by ELISA. Interferon-γ was found to bind to M. bovis BCG in a dose-dependent manner, whereas thermally inactive IFNγ, BSA and other cytokines did not bind to the bacilli (Fig. 1A). To independently analyze the binding of IFNγ to M. bovis BCG, we fixed mycobacteria, then incubated with IFNγ (active or heat-inactivated form), IL12 or BSA, immunostained with antibodies against mycobacterial Hsp65, IFNγ or IL12, and analyzed by fluorescence microscopy. We found that IFNγ, but not its inactive form, IL12 or BSA, binds to mycobacterial cells (Fig. 1B).
To further validate the interaction of IFNγ with M. bovis BCG, we incubated IFNγ with different fixed bacterial strains (M. bovis BCG, M. tuberculosis, M. smegmatis, M. avium, and S. typhimurium), washed and analyzed by immunoblotting using antibodies against mycobacterial RpsO or IFNγ. Interferon-γ was detected only in the M. bovis BCG and M. tuberculosis lysates, confirming the binding and retention of IFNγ on the surface of M. bovis BCG and M. tuberculosis (Fig. 1C). These findings indicate that IFNγ specifically interact with M. bovis BCG and M. tuberculosis, which belong to the M. tuberculosis complex (MTC); therefore, we used M. bovis BCG as a model to investigate the interaction of IFNγ with MTC because of its experimental advantages in the laboratory.
Interferon-γ modulates translational profiles in mycobacteria
To dissect the interaction of IFNγ and pathogenic mycobacteria, M. bovis BCG was treated with IFNγ, heat-inactivated IFNγ, or BSA, followed by comparative proteomic analysis at 24 and 72 h after treatment (Supplemental Dataset 1). The most changed proteins in IFNγ-treated mycobacteria compared to BSA- and inactivated IFNγ-treated mycobacteria were listed in Table 1; at 24 h post-treatment, 23 of 29 (approximately 79.3%) most changed proteins are the reduction while 22 of 23 (approximately 95.6%) most changed proteins were the induction at 72 h post-treatment. The inhibited proteins by IFNγ at 24 h are enzymes involved in different cellular processes, including toxin-antitoxin system, pentose phosphate pathway, glutamine, and lipid metabolism (Fig. 2A). Some of the inhibited proteins such as ribonuclease VapC28, probable alpha-methylacyl-CoA racemase Mcr, ESAT-6-like protein EsxL and possible invasion protein are negative regulators of mycobacterial growth [15, 51], suggesting the inhibition of these proteins by IFNγ may provide growth advantage for mycobacteria. Notably, a marked inhibition of glucose-6-phosphate 1-dehydrogenase Zwf1, a crucial enzyme of first reaction in the pentose phosphate pathway, suggests interferon-γ may trigger carbon metabolism remodeling, an underlying mechanism to survive inside the host cells and to develop drug tolerance and resistance of mycobacteria [18, 41]. In addition, elevated expression of toxin RelK, heat shock protein Hsp, and myo-inositol-1-phosphate synthase Ino1 may benefit mycobacteria in response to oxidative and heat stresses, antibiotic treatment and host defenses [25, 32, 58].
Furthermore, prolonged treatment of IFNγ promotes mycobacteria to a virulence phenotype; a variety of growth effectors and major virulence factors were elevated in IFNγ-treated mycobacteria compared to BSA- and heat-inactivated IFNγ-treated cells at 72 h post-treatment (Fig. 2B). Increased expression of crucial enzymes required for pyrimidine metabolism (dCTP deaminase Dcd), mRNA translation (leucine-tRNA ligase LeuS and lysine-tRNA ligase LysS), and cell wall biosynthesis (myo-inositol-1-phosphate synthase Ino1, methoxy mycolic acid synthase 1 MmaA1, probable acyl-[acyl-carrier protein] desaturase DesA1, probable fatty-acid-CoA ligase FadD22, fatty-acid-CoA ligase FadD28, and phenolpthiocerol synthesis type-I polyketide synthase PpsB) may promote mycobacterial replication, infectivity and pathogenicity. Particularly, the elevation of PpsB and FadD28 may elevate the production of phenolpthiocerol and phthiocerol dimycocerosate (dim), a major lipid virulence factor that modifies physical properties of host cell membranes to promote mycobacterial invasion and allow bacilli to escape from host immune responses [4, 5]. Likewise, the increase of FadD22 may lead to the rise of phenolic glycolipids (PGLs) which exert anti-bactericidal activity by inhibiting the production of nitric oxide in mycobacteria-infected macrophages [35], while a marked elevation of MmaA1 may induce the biosynthesis of mycolic acid, a critical determinant of mycobacteria-host interactions [43]. In addition, different essential virulence factors required for mycobacterial growth inside macrophages and mice were also induced by prolonged treatment of IFNγ, including histidine kinase KdpD of two-component regulatory system KDPD/KDPE, crucial machinery sensing environmental signals; mutator protein MutT2 responsible for removing an oxidatively damaged form of guanine from DNA and the nucleotide pool; and amidase AmiD involving in cellular metabolism [53, 54]. These findings suggest that IFNγ can modulate molecular signatures associated with proliferation and virulence in pathogenic mycobacteria via a direct interaction. On the other hand, the interaction with IFNγ also changed the expression of numerous hypothetical proteins; therefore, further functional studies of these uncharacterized proteins may not only elucidate the IFNγ-mycobacteria interaction but also reveal unrecognized virulence strategies of pathogenic mycobacteria.
Secretion of mycobacterial extracellular vesicles is induced by IFNγ
In addition to identifying IFNγ-dependent molecular changes in mycobacteria by proteomics, we investigated the possible morphological changes of mycobacteria induced by IFNγ. M. bovis BCG was incubated with IFNγ or BSA for 72 h and analyzed by transmission electron microscopy (TEM). TEM analysis revealed that IFNγ treatment did not influence the size, shape, and cell envelop structure of M. bovis BCG; however, it triggered the secretion of extracellular vesicles (E.V.s) markedly; numerous membrane vesicles of various sizes, tens to hundreds nanometers in diameter, were found surrounding the IFNγ-treated mycobacteria whereas very few or no membrane vesicles were found in the BSA-treated bugs (Fig. 2C). Extracellular vesicles are critical elements in mycobacterial pathogenesis. They are membrane-bound structures carrying a variety of macromolecules and are released to promote environmental and host adaptation of mycobacteria [40, 46, 64]. Therefore, these data suggest that IFNγ promotes mycobacteria to a virulent phenotype.
Interferon-γ promotes mycobacterial growth in culture
Findings from proteomic and TEM analyses suggest that interaction with IFNγ may impact mycobacterial growth and infection. We first evaluated the in vitro growth of M. bovis BCG in the presence of different concentrations of IFNγ, TNFα, IL1β, and IL12 by the colony-forming unit (CFU) method. Interferon-γ was found to enhance M. bovis BCG proliferation in a dose-dependent manner, whereas no other cytokines affected bacterial growth (Fig. 2D). In addition, we treated M. smegmatis, M. avium, and S. typhimurium with IFNγ, and analyzed their growth using the CFU method. We found that IFNγ supplementation did not alter the growth of M. smegmatis (Fig. 2E), M. avium (Fig. S1A) and S. typhimurium (Fig. S1B) at any concentration, which was possibly due to IFNγ does not interact with these bacterial species as shown in Fig. 1C. These data indicate that interaction with IFNγ promotes M. bovis BCG growth in vitro.
Interaction with host IFNγ boosts intracellular growth of pathogenic mycobacteria in macrophages
Previous studies have demonstrated IFNγ production at transcriptional and translational levels by various types of mouse and human macrophages [8] upon stimulation of IL12 and IL18 combination [6, 14, 33], IFNγ per se [17], U.V. exposure [66] or infections of Salmonella typhimurium [24, 38], Legionella pneumophila [52] and Chlamydia pneumoniae [21, 47,48,49, 55]. Interestingly, the combination of IL12 and infection of M. bovis BCG or M. tuberculosis is capable of inducing IFNγ production in human and mouse alveolar macrophages (AM), the primary conduit of infection [19, 44, 63], suggesting pathogenic mycobacteria may sense IFNγ to facilitate their intracellular growth in macrophages. To test this hypothesis, we infected control or IFNγ-expressing macrophages with M bovis BCG for 24 h and analyzed the intracellular localization of IFNγ using subcellular fractionation followed by immunoblotting. Cells treated with 0.8 μm latex bead for 4 h were used as controls. Mycobacterial HSP65 was detected only in the phagosomal fraction, suggesting that M. bovis BCG resides primarily in the phagosomes during the first 24 h after infection, while IFNγ was found predominantly in the cytosolic fraction but also in the phagosomal fraction where mycobacteria were present (Fig. 3A), suggesting a possible interaction of mycobacteria with IFNγ inside phagosomes. In addition, IFNγ was also detected in latex bead-containing phagosomes, suggesting that the translocation of IFNγ to phagosomes is solely regulated by host macrophages, not by pathogens. Interferon-γ production by macrophages is a poorly characterized phenomenon; therefore, the mechanism of IFNγ translocation to phagosomes remains to be discovered. However, previous studies of activated T.H. cells, natural killer cells and eosinophils suggest that IFNγ is likely secreted through the conventional protein secretion (CPS) pathway [12, 23, 60]; IFNγ is transported from the endoplasmic reticulum to the Golgi apparatus and subsequently to the plasma membrane via secretory vesicles or secretory granules, implying that IFNγ may also be delivered to phagosomes, plasma membrane-bound vacuoles by a secretory compartment. However, further studies using a combination of molecular, biochemical and biophysical techniques are needed to elucidate the intracellular trafficking mechanism of IFNγ in macrophages.
We next infected control or IFNγ-expressing macrophages with M. bovis BCG and analyzed mycobacterial growth in macrophages using the CFU method. In control macrophages, mycobacteria were internalized and proliferated at first 24 h post-infection but were then eliminated by macrophages at later time points, while IFNγ expression reduced mycobacterial burden at 24 h post-infection but markedly increased mycobacterial growth at later time points compared with control cells (Fig. 3B), suggesting that IFNγ can induce the growth of intracellular mycobacteria similar to cultured mycobacteria (Fig. 2D). However, IFNγ was exported to the extracellular matrix once produced (Fig. S2), where it can bind to the IFNγ receptor 1 (CD119) to trigger mycobactericidal activities in macrophages. Therefore, to define whether the outgrowth phenotype of mycobacteria in IFNγ-expressing macrophages is due to a host-mediated impact of IFNγ or to a direct effect of IFNγ per se, we supplemented antibodies against CD119 to intercept the host IFNγ signaling (Fig. S3) following infection of control or IFNγ-expressing macrophages with M. bovis BCG and then analyzed the intracellular growth of mycobacteria. We found that blocking IFNγ signaling did not influence the intracellular growth of mycobacteria in control macrophages, which do not produce IFNγ (Fig. S2), but significantly enhanced mycobacterial growth in IFNγ-expressing cells in a dose-dependent manner (Fig. 3C), suggesting the mycobacterial outgrowth phenotype in IFNγ-expressing macrophages in Fig. 3B is due to a direct effect of IFNγ.
To independently examine the direct effect of IFNγ on the intracellular mycobacterial growth, we mixed equivalent amounts of control and IFNγ-expressing macrophages, infected with mCherry-M. bovis BCG, and analyzed bacterial burden in each cell type by flow cytometry. At 2 h post-infection, the bacterial load in the two cell types was similar, while at 72 h post-infection, the bacterial burden in IFNγ-expressing macrophages was significantly higher than that in the control cells (Fig. 3D), indicating intracellular IFNγ directly boost mycobacterial growth in macrophages. Interestingly, the concentrations of IFNγ that enhanced intracellular growth of mycobacteria in macrophages (Fig. 3E) were comparable to those produced by activated human T cells [10], human PBMC stimulated by M. tuberculosis antigens or M. tuberculosis [56, 61], or detected in lung homogenates of M. tuberculosis-infected mice [50], and were remarkably lower than the concentrations that promote mycobacterial growth in culture (Fig. 2D), suggesting that intracellular mycobacteria may be more sensitive to IFNγ than cultured mycobacteria. Therefore, to test this assumption, we isolated M. bovis BCG from macrophages at 24 h post-infection, cultured in the culture broth, treated with IFNγ, and analyzed its growth. We found that isolated and cultured mycobacteria grew similarly in cultures without IFNγ treatment; however, IFNγ promoted the growth of isolated mycobacteria one day prior cultured mycobacteria, and the IFNγ-induced growth increase was more remarkable in isolated mycobacteria than in cultured mycobacteria (Fig. 3F). In addition, the expression level of mmpL10 was elevated in intracellular mycobacteria compared with cultured mycobacteria, and IFNγ treatment did not influence mmpL10 expression (Fig. 3G). These data suggest that exposure to the host intracellular environment sensitizes mycobacteria to IFNγ, thereby allowing them to enhance intracellular growth.
To further validate the impact of IFNγ sensing mechanism on mycobacterial infection, we infected control or IFNγ-expressing macrophages with M. tuberculosis and non-pathogenic M. smegmatis, and then analyzed their intracellular growth. Similar to M. bovis BCG (Fig. 3B), M. tuberculosis was found to readily proliferate within macrophages, and the ability to sense IFNγ (Fig. 1C) allowed it to boost intracellular growth in macrophages (Fig. 3H). In contrast, M. smegmatis was rapidly cleared by macrophages, and expression of IFNγ further enhanced this clearance perhaps by enhancing the anti-bacterial effects (Fig. 3I).
Our findings clearly indicate that sensing host IFNγ is a crucial virulent strategy of pathogenic mycobacteria to promote their intracellular growth in macrophages.
Interferon-γ-dependent induction of PpsB and AmiD promotes M. Tuberculosis growth in macrophages
To investigate the molecular mechanism via which IFNγ facilitates M. tuberculosis growth in macrophages, we focused on mycobacterial proteins that are induced by IFNγ (Table 1, Dataset 1). Phenolpthiocerol synthesis type-I polyketide synthase (PpsB) and amidase (AmiD) were most induced by IFNγ in M. bovis BCG, therefore, we examined whether IFNγ could directly modulate the expression of their homologs, PpsB (Rv2932) and AmiD (Rv3375) in M. tuberculosis. We cultured M. tuberculosis in the presence of 10 µg/ml BSA, IFNγ or TNFα, and analyzed the expression of PpsB and AmiD at different time points by immunoblotting. We were unable to detect PpsB and AmiD at their physiological levels, however, treatment of IFNγ but not TNFα markedly elevated the expression of PpsB and AmiD in M. tuberculosis (Fig. 4A).
We next analyzed PpsB and AmiD expression in the context of infection. We infected control or IFNγ-expressing macrophages with M. tuberculosis, and intracellular bacteria were isolated from macrophages at different time points for immunoblot analysis. Mycobacteria isolated from control macrophages displayed a higher expression level of PpsB but not AmiD at 48 and 72 h post-infection compared with cultured bacteria, whereas mycobacteria isolated from IFNγ-expressing cells showed increased expressions of both proteins at all time points compared with cultured bacteria (Fig. 4B), suggesting intracellular IFNγ is capable of triggering PpsB and AmiD expression in M. tuberculosis within macrophages.
The marked induction of mycobacterial PpsB and AmiD by IFNγ in culture and within macrophages suggests the potential importance of PpsB and AmiD in M. tuberculosis infection that remains unknown. Therefore, we generated ppsB-overexpressing (S-PpsB), ppsB-knockdown (AS-PpsB), amiD-overexpressing (S-AmiD) and amiD-knockdown (AS-AmiD) M. tuberculosis strains, characterized (Fig. 4, C and D; upper panel), infected them to macrophages, and analyzed their intracellular growth using the CFU method. We found that overexpression of ppsB or amiD gene enhanced intracellular M. tuberculosis growth while knockdown of ppsB or amiD gene dampened intracellular M. tuberculosis growth (Fig. 4, C and D; lower panel), indicating that ppsB and amiD are essential virulence factors of M. tuberculosis although amiD is expressed at a negligible level under physiological condition and during infection (Fig. 4, A and B).
Taken together, our findings suggest that IFNγ-dependent induction of PpsB and AmiD is an important virulence mechanism of M. tuberculosis to promote its growth in macrophages.
Discussion
Interferon-γ is an indispensable immune effector, activating a robust protective-immune response against mycobacterial infection [20, 29], however, similar to P. aeruginosa which recognizes host cell activation through sensing IFNγ [65], pathogenic mycobacteria can also sense IFNγ (Fig. 1) to advance their pathogenesis. Direct interaction with IFNγ triggers mycobacteria to a virulence phenotype, secretion of extracellular vesicles and upregulation of numerous virulence factors (Fig. 2, B and C), thereby promoting mycobacterial growth in culture (Fig. 2D) and in macrophages (Fig. 3B).
Macrophages are essential effectors acting on the front-line of host defense against mycobacterial infection. Upon activation of IFNγ, macrophages exhibit a potent capacity to kill internalized mycobacteria [20]. However, the ability of pathogenic mycobacteria to survive in naïve and IFNγ-activated macrophages, and growing evidence that macrophages can produce IFNγ in response to various stimuli, including mycobacterial infection [19, 44, 63], suggest that sensing host IFNγ may be an important survival mechanism of pathogenic mycobacteria within macrophages. Although we showed the interaction of pathogenic mycobacteria with IFNγ in culture (Fig. 1, A-C); the binding of IFNγ from intracellular mycobacteria remains biochemically unclear due to technical limitations. However, corroborating the observations in cultured mycobacteria (Fig. 2D), exposure to IFNγ in phagosomes (Fig. 3A) leads to a marked increase of mycobacterial growth in macrophages (Fig. 3, B and D) that occurs independently of host IFNγ signaling (Fig. 3C), suggesting that intracellular mycobacteria perhaps sense host IFNγ to boost their growth in macrophages. Inhibition of IFNγ signaling elevated mycobacterial growth in IFNγ-expressing macrophages (Fig. 3C) and IFNγ-expressing macrophages produced significantly higher NO than control cells (Fig. S3), indicating that autocrine signaling of IFNγ exerts anti-mycobacterial effects in these cells. However, the significant increase of mycobacterial growth induced by intracellular IFNγ (Fig. 3, B and H) suggests that macrophage-derived IFNγ is more beneficial to mycobacterial infection than host immunity. Furthermore, cultured M. bovis BCG only senses IFNγ at concentrations above 1 µg/ml (Fig. 2D), and binding capacity of IFNγ to cultured M. tuberculosis is greater than that of M. bovis BCG (Fig. 1C), therefore in the previous study [2] the authors observed only the interaction of M. tuberculosis but not B. bovis BCG with IFNγ at concentrations less than 1 µg/ml. However, the host intracellular environment sensitizes mycobacteria to IFNγ through enhancing expression of mmpL10 (Fig. 3G), thereby allowing intracellular mycobacteria to sense IFNγ at near-physiological concentrations (Fig. 3, B, E and H) [10, 50, 56, 61] approximately 200 times lower than that perceived by cultured mycobacteria (Fig. 2D). Although the ability of intramacrophage mycobacteria to sense IFNγ at near-physiological concentrations suggests the potential importance of this virulence mechanism in mycobacterial infection in human, further studies identifying host factor(s) that impact mmpL10 expression are needed to enhance our understanding of how mycobacteria are transformed into a virulence phenotype in host macrophages.
Proteomics analysis reveals that multiple molecular signatures associated with mycobacterial proliferation and virulence are induced by IFNγ, among which AmiD, PpsB, and Dcd are the most induced but not fully characterized proteins (Table 1, Dataset 1). Besides being required for optimal growth of M. tuberculosis in mouse spleen [54], AmiD was identified as one of the culture filtrate proteins elevated most in prevalent M. tuberculosis strains compared with the laboratory strain M. tuberculosis H37Rv [26] and the target of HPOX, a new promising inhibitor against M. tuberculosis [34]. On the other hand, ppsB was found to be upregulated greater than 10-fold in rifampicin-resistant mutant M. tuberculosis relative to wild-type strain during infection of activated macrophages [7]. These studies suggest that ppsB and amiD could be important downstream targets of IFNγ in mycobacteria. Therefore, after uncovering that IFNγ markedly induced PpsB and AmiD expression in cultured and intracellular M. tuberculosis (Fig. 4, A and B), we evaluated the contributions of PpsB and AmiD to M. tuberculosis infection in macrophages. Imitating IFNγ’s effect, overexpression of ppsB or amiD significantly enhanced intracellular mycobacterial growth, whereas inhibition of ppsB or amiD expression diminished intracellular mycobacterial growth (Fig. 4, C and D; lower panel), indicating ppsB and amiD are not only important virulence factors but are also important mediators of IFNγ-dependent M. tuberculosis infection in macrophages. In addition to PpsB and AmiD, IFNγ also induces numerous other essential metabolism-related proteins (Fig. 2, A and B, Table 1), suggesting that the interaction with IFNγ can alter metabolic profile in mycobacteria. Therefore, identifying the IFNγ-induced metabolic signatures in mycobacteria could advance our understanding of how mycobacteria enhance their survival and growth in the host cells. On the other hand, the previous studies have shown that dcd homolog in M. marinum is specifically expressed in host granulomas but not in cultured macrophages [42], and the elevation of IFN-γ leads to an exacerbation of M. tuberculosis infection in mice [50] and tuberculosis reactivation in human [27], suggesting that IFNγ-dependent outgrowth of mycobacteria may be an unknown mechanism of tuberculosis activation and Dcd plays a central role in this mechanism. Therefore, further functional investigations of Dcd may uncover long-standing mysteries of tuberculosis reactivation. Interestingly, the induction of PpsB and AmiD by IFNγ was consistently observed in both cultured M. bovis BCG (Fig. 2B) and M. tuberculosis (Fig. 4A), and in intramacrophage M. tuberculosis (Fig. 4B), suggesting that the interaction with IFNγ relies on the bacterial state, particularly mmpL10 expression level, however the signaling pathways activated by IFNγ may be highly conserved in M. tuberculosis complex and independent of IFNγ concentrations.
In addition to inducing anti-mycobacterial effects in macrophages; IFNγ can also trigger macrophages to express its own gene [17], raising certain concerns about the contribution of the self-activation mechanism of macrophages to host-mycobacteria interactions. Our findings indicate that the self-activation mechanism may provide an unrecognized niche for the mycobacterial infection as the bacilli can sense intracellular IFNγ to promote their growth within macrophages, therefore providing a typical example of the coevolution of pathogenic mycobacteria with their host macrophages. Interferon-γ induces outgrowth of intracellular mycobacteria by increasing their proliferative activity and activating multiple virulence mechanisms that enable mycobacteria to resist bactericidal effects and adapt to harsh intracellular environment inside the host cells. Therefore, this study does not only represent a hitherto unknown virulence strategy of pathogenic mycobacteria during infection, but may also pave the way for therapeutic approaches to treat mycobacterial diseases.
Materials and methods
Reagents
Antibodies and reagents used in this study were from the following sources: mouse anti-PpsB, anti-AmiD, and anti-RpsO antibodies were generated by injection of full-length recombinant M. tuberculosis PpsB, AmiD, or RpsO (100 µg) in 100 µl incomplete Freund’s adjuvant (Sigma, #F5506) to BALB/c mice on weeks 0, 2 and 5. Ten days after the final injection, serum samples were obtained, and ELISA was performed to determine the antibody titer; recombinant mouse IFNγ protein (#ab259378), recombinant mouse IL12 protein (#ab259419), recombinant mouse IL1β protein (#ab259421), recombinant mouse TNFα protein (#ab259411), and TMB ELISA substrate (#ab171523) from Abcam; mouse monoclonal anti-β-actin antibody (#3700S) from Cell Signaling; recombinant mouse IFNγ protein (#IF005) and glass bead (#G8772) from Sigma; recombinant mouse IL1β protein (#BMS332), recombinant mouse IL18 protein (#PMC0184), IFNγ rabbit monoclonal antibody (#701121), IFNγ monoclonal antibody (clone XMG1.2), eBioscience (#14-7311-81), rat anti-mouse IL12 p70 (clone 9A5) (#ENMM120), rabbit anti-mouse IL1β (#500-P51), rabbit anti-mouse IL18 (#210-401-323 S), rat IgG1 kappa isotype control (eBRG1), eBioscience (#14-4301-82), goat anti-rabbit IgG-HRP (#31460), goat anti-rat IgG-HRP (#31470), geneticin selective antibiotic (G418 Sulfate) (#10131035), and fluoromount-G mounting medium (#00-4958-02) from Thermo Fisher Scientific; FITC anti-mouse IFNγ antibody (#505806), FITC goat anti-rat IgG antibody (#405404), and Alexa fluor 647 anti-mouse IgG1 antibody (#406618) from BioLegend; rat anti-mouse IFNγ receptor 1 (CD119) (clone GR-20) and rat IgG2a isotype control (clone 2A3) from BioXCell; and heat shock protein 65 (mycobacterial) monoclonal antibody (clone 4H11) (#ADI-SPA-882-E) from Enzo Life Science.
Bacterial and cell culture
M. tuberculosis H37Rv (ATCC, #25618), M. bovis BCG Pasteur (ATCC, #35734), M. avium (ATCC, #25291), M. smegmatis mc2 155 (ATCC, #700084) were cultured in 7H9 media (Fisher Scientific, #DF0713-17-9) supplemented with 10% OADC enrichment (Fisher Scientific, #B12351) while S. typhimurium (ATCC, #14028) was cultured in L.B. media at 37 oC until the stationary phase. M. tuberculosis H37Rv was cultured at a biosafety laboratory level 3 containment facility. M. bovis BCG-mCherry was generated by transforming pMSP12::mCherry to M. bovis BCG. The pMSP12::mCherry plasmid was a gift from Lalita Ramakrishnan (Addgene plasmid #30169; http://n2t.net/addgene:30169; RRID: Addgene_30169).
Mouse macrophages RAW 264.7 (ATCC, #TIB-71) were grown in RPMI 1640 (Thermo Fisher Scientific, #11875093) supplemented with 10% FBS (Thermo Fisher Scientific, #26140079), and 1% penicillin/streptomycin (Gibco, #15140122). Cells were incubated in a 37 oC humidified incubator with 5% CO2.
Gene overexpression and knockdown in M. Tuberculosis
Overexpression and knockdown of ppsB or amiD in M. tuberculosis were performed as previously described [59]. Briefly, the ppsB (4,617 bp) or amiD (1,429 bp) genes were amplified by PCR using the primer pairs (PpsB-forward primer, CCG AAG CTT GTG ATG CGA ACG GCT TTC AGC and PspB-reverse primer, CCG AAG CTT TCA TTG TGT TCC TCT TAG TCG; AmiD-forward primer, CCG AAG CTT ATG ACC GAT GCT GAC AGT GCG and AmiD-reverse primer, CCG AAG CTT TCA CAC CGG CGG GCG TCG GC; HindIII site underlined), and cloned into pMV261 (4,488 bp) cut at HindIII of the multi-cloning site. Positive clones were digestion checked by PvuII. Overexpression clones (sense orientation) would give fragments of approximately 6.25 and 2.85 kbp (ppsB) or 5.75 and 0.17 kbp (amiD), while knockdown clones (anti-sense orientation) would give pieces of roughly 7.3 and 1.8 kbp (ppsB) or 4.64 and 1.27 kbp (amiD). The plasmids were then electroporated into competent M. tuberculosis, followed by immediate culture in an antibiotic-free 7H9 broth for 2 days and plating on 7H10 agar plates containing 25 µg/ml kanamycin.
Generation of IFNγ-overexpressing macrophages
RAW 264.7 cells were transfected with the control pcDNA3.1 (Thermo Fisher Scientific, #V79020), or pcDNA3.1::Ms IFNγ (GenScript, #Omu18252) plasmids using Lipofectamine 3000 transfection reagent (Thermo Fisher Scientific, #L3000008). The cells were cultured in an antibiotic-free culture medium for 2 days, followed by a selection of 1.5 mg/ml G418 (Thermo Fisher Scientific, #10131027) for 12 days. The medium was replaced every 4 days. Production of interferon-γ was validated by immunoblotting and ELISA.
Infection assay
Bacterial growth inside macrophages was evaluated by colony-forming unit (CFU) assay as previously described [62]. Briefly, control or IFNγ-expressing macrophages were infected with M. bovis BCG, M. tuberculosis or M. smegmatis at MOI of 10 for 1 h, followed by an incubation with culture medium containing Amikacin (200 µg/ml) for 2 h to kill extracellular bacteria, and re-cultured in antibiotic-free culture medium. At indicated times; cells were washed three times with PBS, lysed in ddH2O for 10 min at 37oC, serially diluted in PBS, and plated on 7H10 agar plates. Bacterial CFU was determined after 3–4 weeks (M. bovis BCG and M. tuberculosis) or 4 days (M. smegmatis) of incubation at 37 oC.
For the blocking assay, anti-IFNγ receptor 1 (CD119) antibody or isotype control were concurrently treated with infection at concentrations of 5 and 50 µg/ml. Intracellular growth of mycobacteria was evaluated by the CFU assay as described above.
Chimera assay
Wild-type and IFNγ-expressing macrophages were mixed at a 1:1 ratio 4 h before infection with M. bovis BCG-mCherry at MOI of 10 for 1 h, followed by incubation with culture medium containing Amikacin (200 µg/ml) for 2 h, and re-cultured in antibiotic-free culture medium. At indicated times, cells were washed with PBS, fixed with 4% paraformaldehyde at 37 oC for 30 min, permeabilized in 0.2% saponin in PBS for 30 min at room temperature, and blocked with 2% goat serum in PBS (blocking buffer) at room temperature for 1 h. Cells were incubated with FITC anti-IFNγ antibody (1:200 dilution in blocking buffer) for 1 h at room temperature, washed with PBS, resuspended in 200 µl FACS buffer (PBS, 2% FCS, 0.1% NaN3, 5 mM EDTA), and analyzed by the BD FACS CantoII Analyzer. The results were analyzed with FlowJo software (Tree Star).
Bacterial growth with cytokine supplementation
Bacteria were collected in the stationary phase, washed with PBS, adjusted to OD600 = 0.1 by appropriate media, and then cultured 5 ml of bacterial suspensions in 50 ml Falcon tubes with the addition of different concentrations of cytokines. At indicated times, 20 µl bacterial suspensions were collected, diluted in PBS, plated on 7H10 (mycobacteria) or L.B. (Salmonella) agar plates, and incubated in 37 oC for 3–4 weeks (M. bovis BCG and M. tuberculosis), 4–6 days (M. smegmatis), 10–14 days (M. avium) or 1 day (S. typhimurium) for CFU determination.
To investigate the impact of intramacrophage environment on the response of mycobacteria to IFNγ, we inoculated nearly equal amounts of cultured M. bovis BCG (5.7 × 107, 4.9 × 107, and 7.6 × 107 CFU in three biological replicates, respectively) and isolated intracellular M. bovis BCG (approximately 3.8 × 107, 6.4 × 107, and 6.1 × 107 CFU in three biological replicates, respectively) in 2 ml of 7H9 media without or with 10 µg/ml IFNγ supplementation. At the indicated time points, the inoculum was serially diluted in PBS, plated on 7H10 agar plates, and incubated at 37 oC for 3–4 weeks. The normalized growth rate was calculated as the CFU values divided by their initial CFU values. The above-mentioned amounts of cultured mycobacteria corresponded to 0.5 ml of stationary phase M. bovis BCG at OD600 of 0.1, whereas the above-mentioned amounts of intracellular mycobacteria were isolated from 10 150-mm macrophage dishes (2 × 107 cells/dish) infected with M. bovis BCG at an MOI of 10 for 24 h.
Cytokine quantification
The secretion of IFNγ from macrophages was analyzed by sandwich ELISA. Control or IFNγ-expressing macrophages were infected with M. bovis BCG for 1 h followed by a 48 h chase. IFNγ concentration in culture supernatant was analyzed using a mouse IFNγ quantikine ELISA kit (R&D Systems, #MIF00) according to the manufacturer’s instructions.
ELISA binding assay
Binding of IFNγ to mycobacteria was evaluated as previously reported [65]. Briefly, M. bovis BCG harvested in the stationary phase was washed with PBS and fixed in 4% paraformandehyde for 30 min at room temperature. The fixed bacteria were adjusted to OD600 = 0.4 with PBS and coated in the MaxiSorp ELISA plate by carbonate-bicarbonate coating buffer (pH9.6) overnight. Nonspecific binding sites were blocked with 3% BSA for 1 h at room temperature, followed by the addition of varying concentrations of IFNγ, heat-inactivated IFNγ, BSA, IL12, IL1β or IL18, and incubated overnight at 4 oC. Samples were washed and incubated with rat anti-mouse IFNγ (clone XMG1.2), rat anti-mouse IL12 (clone 9A5), rabbit anti-mouse IL1β, or rabbit anti-mouse IL18 at a dilution of 1:1,000 for 2 h at room temperature. Goat HRP-conjugated anti-rat or goat HRP-conjugated anti-rabbit antibody was added to the washed samples at 1:10,000 dilution and incubated for 1 h at room temperature. TMB was then added as a substrate and the reaction was read at 450 nm after the addition of stop solution.
Fluorescence microscopy
M. bovis BCG harvested in the stationary phase was washed with PBS, fixed in 4% paraformandehyde for 30 min at room temperature, blocked with 3% BSA for 1 h at room temperature, and incubated with 10 µg BSA, IL12, IFNγ or heat-inactivated IFNγ overnight at 4 oC. After washing, bacteria were stained with mouse anti-HSP65 and FITC rat anti-IFNγ or rat anti-IL12 at 1:50 dilution for 2 h at room temperature. Bacteria were washed and incubated with Alexa 674 rabbit anti-mouse IgG and/or FITC goat anti-rat IgG at 1:50 dilution for 1 h at room temperature. Bacteria were washed, fixed to the slide, mounted with Fluoromount-G mounting medium and analyzed using a laser scanning confocal microscope (Olympus FV1000, Japan) followed by image processing by the FV10-ASW Viewer 3.1 software.
Transmission electron microscopy
M. bovis BCG was cultured in the presence of 10 µg/ml BSA or IFNγ for 72 h, collected, and then fixed in a fixative containing 2.5% glutaraldehyde and 3 mM CaCl3 in 0.1 M cacodylate buffer for 1 h at room temperature. After washing with 0.1 M cacodylate buffer containing 3 mM CaCl3, the cells were post-fixed for 1 h at 4 °C in 0.1 M cacodylate buffer containing 1% osmium tetroxide and 1.5% potassium ferricyanide. The samples were washed briefly in distilled water, followed by gradual dehydration in a graded ethanol series of 70%, 90%, 95% (15 min per stage), and then 100% (three times and 30 min each time). The dehydrated samples were then infiltrated in stages with spur resin–ethanol solutions containing 50%, 75%, and 100% resin (1 h per stage). The infiltrated samples were left in 100% spurr resin overnight. Next, samples were embedded in the models with fresh resin and polymerized at 70 °C for 24 h. The embedded cells were cut using an ultramicrotome (Ultracut S, Leica Reichart) into 70 nm ultrathin sections using a diamond knife and then post-stained with uranyl acetate and lead citrate. Transmission electron microscopy was carried out on a JEOL JEM-1400 at 120 keV equipped with CCD Camera System (Ultrascan, Gatan).
LC-MS/MS analysis
M. bovis BCG was cultured in the presence of 10 µg/ml BSA, IFNγ or heat inactivated IFNγ for 24 and 72 h. Bacteria were collected, washed with PBS and TEN buffer (75 mM Tris-HCl pH8.8, 4 mM EDTA, 100 mM NaCl), and resuspended in TEN buffer. Bacterial suspension was mixed with glass bead and subjected to homogenization at 5,000 rpm using Minilys personal homogenizer (Bertin Corp, #P000673-MLYS0-A). After centrifugation at 12,000 xg for 10 min at 4 oC, bacterial protein was collected as supernatant, quantified by BCA assay, mixed with 4 volumes of ice-cold acetone, and incubated overnight at -80 °C. Samples were pelleted by 15,000 g for 10 min at 4 °C). The pellet was washed in ice-cold acetone for three times followed by repeated pelleting. Protein pellets were dissolved in 6 M urea and a total of 20 µg proteins from each sample were used. Proteins were reduced by incubation with 10 mM dithiothreitol (DTT) for 1 h at 29 °C and alkylated by 55 mM iodoacetamide (IAA) for 1 h at room temperature in the dark. This step was quenched by 55 mM DTT for 45 min. Protein digestion was performed overnight at 37 °C using mass spectrometry grade modified trypsin (Promega) at a 1:50 trypsin/protein ratio. After overnight incubation, 0.1% TFA was added to stop the digestion. Finally, all remaining reagents from the in-solution digestion procedure were removed using C18 stage tip.
LC-MS/MS analysis was performed on a Orbitrap Fusion Lumos Tribrid quadrupole-ion trap-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with a NanoSpray ion source. Peptides were separated on an Ultimate system 3000 nanoLC system (Thermo Fisher Scientific, Bremen, Germany). Peptide mixtures were loaded onto a 75 μm ID, 25 cm length C18 Acclaim PepMap NanoLC column (Thermo Scientific, San Jose, CA, USA) packed with 2 μm particles with a pore of 100 Å. Mobile phase A was 0.1% formic acid in water, and mobile phase B was composed of 100% acetonitrile with 0.1% formic acid. A segmented gradient in 90 min from 2 to 35% solvent B at a flow rate of 300 nl/min and a column temperature of 35 °C were used. Mass spectrometry analysis was performed in a data-dependent mode with Full-MS (externally calibrated to a mass accuracy of < 5 ppm, and a resolution of 120,000 at m/z = 200, AGC target 5e5, maximum injection time of 50 ms) followed by HCD-MS/MS of the most intense ions in 3 s. High-energy collision activated dissociation (HCD)-MS/MS was used to fragment multiply charged ions within a 1.4 Da isolation window at a normalized collision energy of 32. AGC target 5e4 was set for MS/MS analysis with previously selected ions dynamically excluded for 60 s. Max injection time of 50 ms. Ions were detected at Orbitrap with resolution 15,000.
The raw MS/MS data were searched against the UniProt knowledgebase reviewed M. bovis BCG Pasteur 1173P2 protein database (downloaded on April 2022) by using the Mascot search algorithm (version 2.3) via the Proteome Discoverer (PD) package (version 2.2, Thermo Scientific). The search parameters were set as follows: peptide mass tolerance, 10 ppm; MS/MS ion mass tolerance, 0.02 Da; enzyme set as trypsin and allowance of up to two missed cleavages; variable modifications included oxidation on methionine, deamidation on asparagine and glutamine residues, and carbamidomethylation of cysteine residues. Peptides were filtered based on a 1% FDR. For relative protein quantification across different samples, each protein group is represented by a single master protein (P.D. Grouping feature) and the raw abundance of each protein was normalized by total abundance [36]. Data are available via ProteomeXchange with identifier PXD038542. Protein expression fold change between two groups was calculated from the average of their three biological replicates. Proteins with at least 1.5 fold changes in IFNγ-treated bacteria but less than 1.5 fold changes in HI-IFNγ-treated bacteria compared with BSA control were selected and statistically analyzed. Proteins that were significantly changed by IFNγ but not by HI-IFNγ were listed in Table 1 and their abundance was presented by heatmap via http://www.heatmapper.ca/.
Intracellular bacteria isolation and immunoblotting
Isolation of intracellular M. tuberculosis from infected macrophages was performed as previously described [31]. In brief, infected cells were washed with PBS and lysed in GTC lysis buffer (4 M guanidine thiocyanate, 0.5% sodium N-lauryl sarcosine, 25 mM tri-sodium citrate, 0.1 M 2-mercaptoethanol, 0.5% Tween-80, pH 7). Bacterial pellet was collected after centrifugation at 5,000 xg for 20 min, washed, and resuspended in TEN buffer. The glass bead was added to the bacterial suspension and subjected to homogenization at 5,000 rpm using Minilys personal homogenizer. After centrifugation at 12,000 xg for 10 min at 4 oC, bacterial protein was collected as supernatant, quantified by BCA assay, and analyzed by immunoblotting with antibodies against PpsB, AmiD and RpsO.
Quantitative RT-PCR
This assay was done as previously described [22, 45] with some modifications. Briefly, M. bovis BCG cultured in the presence of 10 µg/ml BSA or IFNγ was collected at 24 and 72 h post-treatment, whereas intracellular M. bovis BCG was isolated from infected macrophages at 24 h post-infection as reported before [31]. Total ribonucleic acid (RNA) from cultured or intracellular mycobacteria was isolated using the glass bead and TRIzol solution, and residual contaminating genomic DNA was degraded by TURBO DNase (Thermo Fisher Scientific, #AM2238). The complementary DNA (cDNA) was prepared with RevertAid RT reverse transcription kit (Thermo Fisher Scientific, #K1691) and the qRT-PCR was carried out using SYBR Green PCR master mix (Thermo Fisher Scientific, #4039155), primers (mmpL10, forward: 5’-CCG TGA TGT TGC TAG TCA TCT-3’ and reverse: 5’-GCT TGA TTG GAT ACG GCT AGA-3’; rpsO, forward: 5’-AAG GAG ATT CTG CGC TCC TA-3’ and reverse: 5’-CGA ATG ATG GTC GTG CTT GT-3’) and PCR program (95 oC for 10 min, 40 cycles of 95 oC for 15 s and 55 oC for 1 min, increment 0.3 oC to 95 oC for melt curve). The housekeeping rpsO transcript was used for the normalization and the fold changes of transcript were calculated using the 2−ΔΔCT method.
Subcellular fractionation and immunoblotting
Subcellular fractionation was performed as previously described with some modifications [16, 57]. Briefly, macrophages were washed with cold PBS and homogenization buffer (250 mM sucrose, 3 mM imidazole, pH 7.4), harvested, and resuspended in cold homogenization buffer. Cells were homogenized through Dounce homogenizer, followed by centrifugation at 1,000 xg at 4oC for 5 min. The supernatant was collected, brought to 40% sucrose by adding an equal volume of 62% sucrose solution, and loaded onto the cushion of 62% sucrose. The 35, 25, and 10% sucrose solutions were added one after another, followed by centrifugation at 100,000 xg for 1 h at 4oC. The phagosomal fraction was collected at the interface of the 10 and 25% sucrose solutions while the non-phagosome fraction was a mixture of fractions collected at the interfaces beneath other sucrose gradients. The phagosomal fraction was resuspended in cold PBS and centrifuged at 40,000 xg for 15 min at 4oC. Phagosomes were collected as pellet and lysed in RIPA (50 mM Tris-HCl pH7.4, 150 mM NaCl, 1% NP-40, 0.5% Na deoxycholate (NaDOC), 0.1% SDS, 1mM EDTA) buffer containing halt protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Cat# 1861284) in 30 min at 4oC. Protein solution obtained from the supernatant after centrifugation at 10,000 xg for 10 min at 4oC was subjected to subsequent immunoblotting. On the other hand, the non-phagosome fraction was subjected to trichloroacetic acid-mediated protein precipitation, washed with acetone, and centrifuged at 12,000 xg for 5 min at 4oC. The pellet was reconstituted in RIPA buffer containing halt protease and phosphatase inhibitor cocktail, incubated in 30 min at 4oC, and centrifuged at 10,000 xg for 10 min at 4oC. The supernatant was collected and used for subsequent immunoblotting analysis.
Phagosomal and non-phagosome fractions were quantified by BCA protein quantification (Thermo Fisher Scientific, #23225), separated on 10% SDS-PAGE gels, and transferred onto nitrocellulose membranes with semi-dry transfer systems (BioRad, Hercules, CA, USA). The membranes were blocked with blocking buffer (5% BSA in PBS-Tween20) overnight at 4 °C, followed by an incubation of primary antibodies diluted in blocking buffer at 1:2,000 for anti-actin antibody and 1:1,000 for other antibodies for 2 h at room temperature. The membranes were washes, incubated with horseradish peroxidase (HRP)-conjugated secondary antibody for 1 h at room temperature, developed and imaged.
Statistical analyses
Statistical analyses were performed with one-way or two-way ANOVA followed by multiple comparisons among groups in Prism (GraphPad Software). The results are mean values ± standard deviations from three independent experiments unless otherwise defined in the legends. Error bars show standard deviation.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [37] partner repository with the dataset identifier PXD038542.
References
Ahmad F, Rani A, Alam A, Zarin S, Pandey S, Singh H, Hasnain SE, Ehtesham NZ (2022) Macrophage: a cell with many faces and functions in tuberculosis. Front Immunol 13:747799
Ahmed M, Mackenzie J, Tezera L, Krause R, Truebody B, Garay-Baquero D, Vallejo A, Govender K, Adamson J, Fisher H et al (2022) Mycobacterium tuberculosis senses host Interferon-gamma via the membrane protein MmpL10. Commun Biol 5:1317
Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491
Augenstreich J, Haanappel E, Ferre G, Czaplicki G, Jolibois F, Destainville N, Guilhot C, Milon A, Astarie-Dequeker C, Chavent M (2019) The conical shape of DIM lipids promotes Mycobacterium tuberculosis infection of macrophages. Proc Natl Acad Sci U S A 116:25649–25658
Augenstreich J, Haanappel E, Sayes F, Simeone R, Guillet V, Mazeres S, Chalut C, Mourey L, Brosch R, Guilhot C et al (2020) Phthiocerol Dimycocerosates from Mycobacterium tuberculosis increase the membrane activity of bacterial effectors and host receptors. Front Cell Infect Microbiol 10:420
Bastos KR, Barboza R, Sardinha L, Russo M, Alvarez JM, Lima MR (2007) Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. J Interferon Cytokine Res 27:399–410
Bisson GP, Mehaffy C, Broeckling C, Prenni J, Rifat D, Lun DS, Burgos M, Weissman D, Karakousis PC, Dobos K (2012) Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis. J Bacteriol 194:6441–6452
Bogdan C, Schleicher U (2006) Production of interferon-gamma by myeloid cells–fact or fancy? Trends Immunol 27:282–290
Brode S, Macary PA (2004) Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 112:345–351
Bullens DM, Rafiq K, Charitidou L, Peng X, Kasran A, Warmerdam PA, Van Gool SW, Ceuppens JL (2001) Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production. Int Immunol 13:181–191
Bussi C, Gutierrez MG (2019) Mycobacterium tuberculosis infection of host cells in space and time. FEMS Microbiol Rev 43:341–361
Carmo LAS, Bonjour K, Spencer LA, Weller PF, Melo RCN (2018) Single-cell analyses of human eosinophils at High Resolution to understand compartmentalization and vesicular trafficking of Interferon-Gamma. Front Immunol 9:1542
Cooper AM, Mayer-Barber KD, Sher A (2011) Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4:252–260
Darwich L, Coma G, Pena R, Bellido R, Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A et al (2009) Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 126:386–393
DeJesus MA, Gerrick ER, Xu W, Park SW, Long JE, Boutte CC, Rubin EJ, Schnappinger D, Ehrt S, Fortune SM et al (2017) Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis. mBio 8
Desjardins M, Huber LA, Parton RG, Griffiths G (1994) Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol 124:677–688
Di Marzio P, Puddu P, Conti L, Belardelli F, Gessani S (1994) Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages. J Exp Med 179:1731–1736
Eoh H, Liu R, Lim J, Lee JJ, Sell P (2022) Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis. Front Cell Infect Microbiol 12:958240
Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H (1997) Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 65:5149–5156
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249–2254
Fukao T, Frucht DM, Yap G, Gadina M, O’Shea JJ, Koyasu S (2001) Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol 166:4446–4455
Hop HT, Huy TXN, Reyes AWB, Arayan LT, Vu SH, Min W, Lee HJ, Kang CK, Kim DH, Tark DS et al (2019) Interleukin 6 Promotes Brucella abortus Clearance by Controlling Bactericidal Activity of Macrophages and CD8(+) T Cell Differentiation. Infect Immun 87
Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM (2006) T cells use two directionally distinct pathways for cytokine secretion. Nat Immunol 7:247–255
Kirby AC, Yrlid U, Wick MJ (2002) The innate immune response differs in primary and secondary Salmonella infection. J Immunol 169:4450–4459
Korch SB, Malhotra V, Contreras H, Clark-Curtiss JE (2015) The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition. J Microbiol 53:783–795
Kumar G, Shankar H, Sharma D, Sharma P, Bisht D, Katoch VM, Joshi B (2017) Proteomics of culture filtrate of prevalent Mycobacterium tuberculosis strains: 2D-PAGE map and MALDI-TOF/MS analysis. SLAS Discov 22:1142–1149
Langan EA, Graetz V, Allerheiligen J, Zillikens D, Rupp J, Terheyden P (2020) Immune checkpoint inhibitors and tuberculosis: an old disease in a new context. Lancet Oncol 21:e55–e65
Luo G, Niesel DW, Shaban RA, Grimm EA, Klimpel GR (1993) Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun 61:830–835
MacMicking JD, Taylor GA, McKinney JD (2003) Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302:654–659
Mahdavi J, Royer PJ, Sjolinder HS, Azimi S, Self T, Stoof J, Wheldon LM, Brannstrom K, Wilson R, Moreton J et al (2013) Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence. Open Biol 3:130048
Monahan IM, Mangan JA, Butcher PD (2001) Extraction of RNA from Intracellular Mycobacterium tuberculosis: methods, considerations, and applications. Methods Mol Med 54:31–42
Movahedzadeh F, Smith DA, Norman RA, Dinadayala P, Murray-Rust J, Russell DG, Kendall SL, Rison SC, McAlister MS, Bancroft GJ et al (2004) The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence. Mol Microbiol 51:1003–1014
Munder M, Mallo M, Eichmann K, Modolell M (1998) Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 187:2103–2108
Nguyen PC, Delorme V, Benarouche A, Guy A, Landry V, Audebert S, Pophillat M, Camoin L, Crauste C, Galano JM et al (2018) Oxadiazolone derivatives, new promising multi-target inhibitors against M. Tuberculosis. Bioorg Chem 81:414–424
Oldenburg R, Mayau V, Prandi J, Arbues A, Astarie-Dequeker C, Guilhot C, Werts C, Winter N, Demangel C (2018) Mycobacterial phenolic glycolipids selectively disable TRIF-Dependent TLR4 signaling in macrophages. Front Immunol 9:2
Palomba A, Abbondio M, Fiorito G, Uzzau S, Pagnozzi D, Tanca A (2021) Comparative evaluation of MaxQuant and Proteome Discoverer MS1-Based protein quantification tools. J Proteome Res 20:3497–3507
Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ, Prakash A, Frericks-Zipper A, Eisenacher M et al (2022) The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50:D543–D552
Pietila TE, Veckman V, Kyllonen P, Lahteenmaki K, Korhonen TK, Julkunen I (2005) Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 78:909–920
Porat R, Clark BD, Wolff SM, Dinarello CA (1991) Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430–432
Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, Camara C, Nosanchuk JD, Besra GS, Chen B et al (2011) Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest 121:1471–1483
Quinonez CG, Lee JJ, Lim J, Odell M, Lawson CP, Anyogu A, Raheem S, Eoh H (2022) The Role of Fatty Acid Metabolism in Drug Tolerance of Mycobacterium tuberculosis. mBio: e0355921
Ramakrishnan L, Federspiel NA, Falkow S (2000) Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288:1436–1439
Rao V, Fujiwara N, Porcelli SA, Glickman MS (2005) Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201:535–543
Robinson CM, O’Dee D, Hamilton T, Nau GJ (2010) Cytokines involved in interferon-gamma production by human macrophages. J Innate Immun 2:56–65
Rock JM, Hopkins FF, Chavez A, Diallo M, Chase MR, Gerrick ER, Pritchard JR, Church GM, Rubin EJ, Sassetti CM et al (2017) Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol 2:16274
Rodriguez GM, Prados-Rosales R (2016) Functions and importance of mycobacterial extracellular vesicles. Appl Microbiol Biotechnol 100:3887–3892
Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, Rottenberg ME (2001) IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167:6453–6461
Rothfuchs AG, Kreuger MR, Wigzell H, Rottenberg ME (2004a) Macrophages, CD4 + or CD8 + cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol 172:2407–2415
Rothfuchs AG, Trumstedt C, Wigzell H, Rottenberg ME (2004b) Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. J Immunol 172:6345–6353
Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, Barber DL (2016) CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent Lethal Disease. PLoS Pathog 12:e1005667
Sala A, Bordes P, Genevaux P (2014) Multiple toxin-antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel) 6:1002–1020
Salins S, Newton C, Widen R, Klein TW, Friedman H (2001) Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect Immun 69:3605–3610
Sang PB, Varshney U (2013) Biochemical properties of MutT2 proteins from Mycobacterium tuberculosis and M. Smegmatis and their contrasting antimutator roles in Escherichia coli. J Bacteriol 195:1552–1560
Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100:12989–12994
Schleicher U, Hesse A, Bogdan C (2005) Minute numbers of contaminant CD8 + T cells or CD11b + CD11c + NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood 105:1319–1328
Shams H, Wizel B, Weis SE, Samten B, Barnes PF (2001) Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis. Infect Immun 69:3497–3501
Shui W, Sheu L, Liu J, Smart B, Petzold CJ, Hsieh TY, Pitcher A, Keasling JD, Bertozzi CR (2008) Membrane proteomics of phagosomes suggests a connection to autophagy. Proc Natl Acad Sci U S A 105:16952–16957
Stewart GR, Snewin VA, Walzl G, Hussell T, Tormay P, O’Gaora P, Goyal M, Betts J, Brown IN, Young DB (2001) Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7:732–737
Sun J, Wang X, Lau A, Liao TY, Bucci C, Hmama Z (2010) Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS ONE 5:e8769
Swaim CD, Scott AF, Canadeo LA, Huibregtse JM (2017) Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor. Mol Cell 68:581–590 e585
Vivekanandan MM, Adankwah E, Aniagyei W, Acheampong I, Minadzi D, Yeboah A, Arthur JF, Lamptey M, Abass MK, Kumbel F et al (2023) Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment. Infection 51:1013–1023
Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K, Klebl B, Thompson C, Bacher G, Pieters J (2004) Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304:1800–1804
Wang J, Wakeham J, Harkness R, Xing Z (1999) Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 103:1023–1029
Wang J, Wang Y, Tang L, Garcia RC (2019) Extracellular Vesicles in Mycobacterial Infections: Their Potential as Molecule Transfer Vectors. Front Immunol 10: 1929
Wu L, Estrada O, Zaborina O, Bains M, Shen L, Kohler JE, Patel N, Musch MW, Chang EB, Fu YX et al (2005) Recognition of host immune activation by Pseudomonas aeruginosa. Science 309:774–777
Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA et al (2011) Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469:548–553
Acknowledgements
We thank the technical services provided by “the i-MANI center of the National Core Facility for Biopharmaceuticals, Ministry of Science and Technology, Taiwan” as well as the technical services from the Instrument Development Center of the National Cheng Kung University. We also thank Dr. Ching-Hao Teng at National Cheng Kung University, Taiwan for assisting the purchase of bacterial strains used in this study and Chih-Hui Wu for excellent technical assistances.
Funding
This project was supported by Distinguished Scholar Program Grant No. D110-G9603 through the National Cheng Kung University, Taiwan (to HTH).
Author information
Authors and Affiliations
Contributions
Conceptualization: HTH; Methodology: HTH, PCL, HYW; Investigation: HTH, HYW; Visualization: HTH; Funding acquisition: HTH; Manuscript writing: HTH. Manuscript review: PCL, HYW.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The animal husbandry and immunization protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at National Cheng Kung University.
Consent for publication
Not applicable.
Competing interests
Authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hop, H.T., Liao, PC. & Wu, HY. Enhancement of mycobacterial pathogenesis by host interferon-γ. Cell. Mol. Life Sci. 81, 380 (2024). https://doi.org/10.1007/s00018-024-05425-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-024-05425-7